Functional Annotation of ddlB (D-Alanine—D-Alanine Ligase B, Q88N74) in Pseudomonas putida KT2440

Gene / Protein Identity (verified)

Identity check: The gene symbol ddlB, the EC number 6.3.2.4, the ATP-grasp and D-Ala-D-Ala-ligase domain signatures, and the family assignment are fully mutually consistent. This is unambiguously a member of the D-alanine—D-alanine ligase (Ddl) family. There is no evidence of gene-symbol ambiguity; the only caveat is organism-level: essentially all mechanistic and structural work on this enzyme has been performed on orthologues (E. coli DdlB, and Ddl from M. tuberculosis, Y. pestis, T. thermophilus, T. maritima, H. pylori, enterococci). No study is specific to P. putida PP_1339. The function below is therefore assigned to Q88N74 by strong, unambiguous homology/family inference and validated by biochemistry of well-characterized orthologues, most directly the canonical E. coli DdlB, which is the structural reference for the family.

Summary (Answer to the Research Question)

Primary function. ddlB encodes D-alanine—D-alanine ligase B (DdlB, EC 6.3.2.4), a cytoplasmic, ATP-dependent ligase of the ATP-grasp superfamily. It catalyzes the condensation of two molecules of D-alanine into the dipeptide D-alanyl-D-alanine (D-Ala-D-Ala), consuming ATP (2 D-Ala + ATP → D-Ala-D-Ala + ADP + Pᵢ) [PMID 34047462; 35382715]. Its substrate specificity is for D-alanine at both binding subsites; unlike the resistance ligases VanA/VanB, wild-type DdlB strongly disfavours D-lactate/α-hydroxy acids at the second (C-terminal) subsite [PMID 10801495].

Localization. The enzyme functions in the bacterial cytoplasm, catalyzing one of the cytosolic steps of peptidoglycan precursor synthesis [PMID 23286234]. Its product, however, is ultimately consumed extracytoplasmically: the terminal D-Ala-D-Ala of the completed precursor is the substrate/leaving group for periplasmic penicillin-binding-protein transpeptidases and the direct binding target of glycopeptide antibiotics at the cell surface.

Pathway. DdlB provides the D-Ala-D-Ala dipeptide that the ligase MurF adds to UDP-MurNAc-tripeptide, completing UDP-MurNAc-pentapeptide (the Park nucleotide) — the cytoplasmic end-product of the Mur pathway and the muropeptide unit later polymerized and cross-linked into the cell-wall sacculus [PMID 34047462; 35382715].

Detailed Findings

1. Reaction catalyzed and substrate specificity

DdlB catalyzes the ATP-dependent ligation of two D-alanine molecules to form D-Ala-D-Ala:

"D-alanyl-D-alanine ligase (Ddl) is an indispensable adenosine triphosphate-dependent bacterial enzyme … which catalyzes the ligation of two D-alanine molecules into one D-alanyl-D-alanine dipeptide." [PMID 34047462]

The "B" isoform designation reflects the situation in E. coli and many other Gram-negatives, where two paralogous ligases, DdlA and DdlB, both supply D-Ala-D-Ala; either alone is sufficient, and only the ddlA ddlB double mutant is a D-Ala-D-Ala auxotroph, demonstrating that this dipeptide-forming activity is essential for viability [PMID 15948948]. DdlB was directly identified as "responsible for the condensation of two alanines, forming D-Ala-D-Ala" [PMID 35382715].

The enzyme has two D-alanine subsites with distinct affinities. In the M. tuberculosis orthologue, K_m,D-Ala1 = 0.075 mM (N-terminal, high-affinity subsite) and K_m,D-Ala2 = 3.6 mM (C-terminal, low-affinity subsite) [PMID 23286234]. The chemistry of subsite 2 is the key determinant of specificity: naturally vancomycin-resistant and Van-type ligases replace an amide-accepting subsite 2 with one that accepts D-lactate (yielding D-Ala-D-Lac); comparison of the D-Ala-D-Lac ligase structure with wild-type DdlB revealed "alterations in the size and hydrophobicity of the site for D-lactate binding (subsite 2)" and reduced H-bonding to the second substrate [PMID 10801495]. Wild-type DdlB thus is a true D-Ala:D-Ala (amide-forming) ligase.

2. Structure and catalytic mechanism (ATP-grasp fold)

DdlB is one of the three founding members of the ATP-grasp superfamily, alongside biotin carboxylase and glutathione synthetase:

"The founding members of the family consist of biotin carboxylase, d-ala-d-ala ligase and glutathione synthetase, all of which catalyze the ATP-assisted reaction of a carboxylic acid with a nucleophile via the formation of an acylphosphate intermediate." [PMID 21920581]

Mechanistically, the enzyme follows an ordered ter-ter kinetic mechanism: ATP binds first, then the two D-Ala substrates bind sequentially [PMID 23286234]. Catalysis proceeds by (i) phosphoryl transfer from ATP to the carboxylate of the first (N-terminal) D-Ala, generating a D-alanyl-phosphate (acyl-phosphate) intermediate; (ii) nucleophilic attack by the α-amino group of the second (C-terminal) D-Ala, forming the peptide bond and releasing inorganic phosphate. General-base chemistry participates in the catalytic step [PMID 23286234]. The intermediate has been captured structurally with phosphinophosphate transition-state analogs [PMID 10801495].

The protein is built from three domains (N-terminal, central, C-terminal), and catalysis is conformationally gated: flexible loops (the "serine loop" recognizing nucleotide phosphates, and the "ω-loop") and rigid-body rotation of the central domain drive an open → semi-open → closed transition that sequesters the substrates for chemistry [PMID 26894530; 19770507]. Activity is typically stimulated by monovalent cations (K⁺) [PMID 23286234]. Biophysically, recombinant E. coli DdlB is a compact, folded enzyme whose stability peaks near its pI (~5.0) [PMID 35382715].

3. Cellular localization and pathway context

DdlB is a soluble cytoplasmic enzyme acting in the cytosolic phase of peptidoglycan biosynthesis. Its product feeds directly into the Mur ligase cascade: MurF condenses D-Ala-D-Ala onto UDP-MurNAc-L-Ala-γ-D-Glu-meso-DAP (UDP-MurNAc-tripeptide) to produce UDP-MurNAc-pentapeptide [PMID 34047462]. This nucleotide precursor is then transferred to the lipid carrier (lipid I → lipid II), flipped across the membrane, and polymerized; the terminal D-Ala-D-Ala is the acyl-donor recognized by penicillin-binding-protein transpeptidases that cross-link glycan strands in the periplasm/cell wall — i.e., the step "required for subsequent extracellular transpeptidase crosslinking of the mature peptidoglycan polymer" [PMID 35382715].

Direct in-cell evidence that DdlB is the committed dipeptide-forming step comes from inhibitor studies: blocking Ddl produces "an increase in D-Ala intracellular pools accompanied by a commensurate decrease in D-Ala-D-Ala" [PMID 30300845].

4. Physiological / pharmacological significance

Because D-Ala-D-Ala is essential and has no human counterpart, Ddl/DdlB is a validated antibacterial target [PMID 34047462; 32497961]. The D-alanine analog D-cycloserine inhibits Ddl (and alanine racemase), competitively occupying the D-Ala subsites [PMID 23286234; 15948948]. Numerous DdlB-directed inhibitor chemotypes have been developed against the E. coli enzyme (diazenedicarboxamides, thiosemicarbazides, hydroxyethylamine phosphonates, flavonoids such as quercetin/apigenin) [PMID 17267218; 30300845; 19196510; 18774266]. The same subsite-2 chemistry that DdlB enforces (amide, not ester) is what glycopeptides (vancomycin) exploit by binding D-Ala-D-Ala directly; Van-type resistance re-routes the pathway to D-Ala-D-Lac, bypassing this step [PMID 32277698; 10801495]. These points are mechanistically informative for the precise role of PP_1339 in P. putida, though P. putida itself is not a clinical glycopeptide-resistance model.

Supported vs. Refuted Hypotheses

Evidence Quality and Limitations

• Direct experimental evidence for PP_1339 (Q88N74) itself is lacking; no P. putida-specific enzymology, structure, or knockout was found. The functional assignment rests on (a) unambiguous membership in the D-Ala-D-Ala ligase family via HAMAP MF_00047 and multiple InterPro domain signatures, and (b) deep, consistent biochemical/structural characterization of orthologues — most directly E. coli DdlB, the canonical family reference.
• The Ddl family is highly conserved and functionally uniform for the D-Ala:D-Ala reaction; the specificity-determining subsite-2 residues that distinguish D-Ala:D-Ala from D-Ala:D-Lac ligases are well defined, and DdlB-type enzymes are amide-forming. Kinetic parameters (K_m values, K⁺ activation) are expected to differ quantitatively in P. putida but not qualitatively.
• Future directions: direct confirmation for PP_1339 would come from recombinant expression + ADP/phosphate-coupled ligase assays, an AlphaFold/experimental structure superposed on E. coli DdlB to verify the two D-Ala subsites and ATP-grasp loops, and complementation of an E. coli ddlA ddlB auxotroph.

References (PMIDs)

34047462, 35382715, 21920581, 23286234, 26894530, 19770507, 10801495, 15948948, 30300845, 32497961, 17267218, 19196510, 18774266, 32277698, 17090922.